The MagicPad4 sounds sensational, and I can't wait to try it.

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Propranolol is a prescription beta-blocker that has been on the market for decades and is now widely available as a generic.

Vivtex, cofounded by renowned MIT professor Robert Langer, stands to make as much as $2.1 billion if milestones are met.

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.

GMRx2 is an innovative single pill combination of three medicines designed to deliver the blood pressure-lowering benefits of triple combination ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Demand for GLP-1 drugs continues to climb, boosted by a major price drop and the FDA’s approval of an oral Wegovy pill that has already generated more than 26,000 prescriptions in January.

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of ...

Marcan Pharmaceuticals Inc. is recalling two lots of MAR-Amlodipine 5 mg tablets because some bottles may contain the wrong tablets, which they have identified as midodrine 2.5 mg tablets.